DNTH
Dianthus Therapeutics, Inc.
Stock
$88.21−0.11 (−0.12%)Close Oct 2, 2026
- EBITDA, 2025
- −$178M
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | −$178M | — |
| 2024 | −$102M | — |
| 2023 | −$48M | — |
| 2022 | −$28M | — |
| 2021 | −$73M | — |
| 2020 | −$77M | — |
| 2019 | −$81M | — |
| 2018 | −$59M | — |
| 2017 | −$35M | — |
| 2016 | −$9.3M | — |